The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients
F. Muyas, M. J. Gomez Rodriguez, I. Cortes-Ciriano, I. Flores
The paper identifies telomere fusions as a genomic signature of the ALT pathway in cancer, detectable in blood for early cancer detection.
bioRxiv · Jan 25, 2022Cancer Biology